Weekly Update: New diabetes clinical trial (14 items)

New diabetes clinical trial: Maternal and Perinatal Pregnancy Outcome in Women With Heterozygous Hemoglobinopathies Published on: February 11, 2019 at 07:00PM Condition:   Heterozygous Haemoglobinopathy Intervention:   Other: pregnancy outcome Sponsor:   University Hospital, Basel, Switzerland Active, not recruiting https://clinicaltrials.gov/ct2/show/NCT03837119?term=diabetes&sfpd_d=14 February 11, 2019 at 03:04PM via ClinicalTrials.gov New diabetes clinical trial: Lifestyle Intervention in Chronic Ischemic Heart Disease and Diabetes Published on: February 11, 2019 at 07:00PM Conditions:   Ischemic Heart Disease Chronic;   Diabetes Mellitus, Type 2 Interventions:   Behavioral: lifestyle intervention;   Behavioral: usual care Sponsors:   Techniker Krankenkasse;   Technische Universität München;   privates Institut für angewandte Versorgungsforschung GmbH;   IDS Diagnostic Systems AG;   Federal Joint Committee, Germany Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT03835923?term=diabetes&sfpd_d=14 February 11, 2019 at 03:04PM via ClinicalTrials.gov New diabetes clinical trial: GLucose Monitoring Programme SingaporeE (GLiMPSE) Published on: February 12, 2019 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Intervention:   Combination Product: Flash Glucose Monitoring and structured education Sponsors:   Singapore General Hospital;   KK Women's and Children's Hospital;   SingHealth Polyclinics Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT03837262?term=diabetes&sfpd_d=14 February 12, 2019 at 05:04PM via ClinicalTrials.gov New diabetes clinical trial: The Loop Observational Study Published on: February 12, 2019 at 07:00PM Condition:   Diabetes Mellitus, Type 1 Intervention:   Device: Loop Sponsors:   Jaeb Center for Health Research;   Stanford University;   Tidepool Project;   RileyLink Recruiting https://clinicaltrials.gov/ct2/show/NCT03838900?term=diabetes&sfpd_d=14 February 12, 2019 at 05:04PM via ClinicalTrials.gov New diabetes clinical trial: Smartphone Application for the Management of Gestational Diabetes Mellitus Published on: February 12, 2019 at 07:00PM Condition:   Gestational Diabetes Mellitus in Pregnancy Intervention:   Other: Smartphone application Sponsor:   Kangbuk Samsung Hospital Completed https://clinicaltrials.gov/ct2/show/NCT03838380?term=diabetes&sfpd_d=14 February 12, 2019 at 05:04PM via ClinicalTrials.gov New diabetes clinical trial: (R33 Phase) Delish Study: Diabetes Education to Lower Insulin, Sugars, and Hunger Published on: February 12, 2019 at 07:00PM Condition:   Type 2 Diabetes Mellitus Interventions:   Behavioral: Carbohydrate-restricted diet;   Behavioral: Mindfuless Sponsors:   University of California, San Francisco;   National Center for Complementary and Integrative Health (NCCIH) Recruiting https://clinicaltrials.gov/ct2/show/NCT03837405?term=diabetes&sfpd_d=14 February 12, 2019 at 05:04PM via ClinicalTrials.gov New diabetes clinical trial: Flexible Insulin Therapy Untethered Insulin Regimen in Avidly Exercising Patients With Type 1 Diabetes: FIT Untethered Published on: February 12, 2019 at 07:00PM Condition:   Type 1 Diabetes Mellitus Intervention:   Drug: Insulin Degludec Sponsor:   LMC Diabetes & Endocrinology Ltd. Recruiting https://clinicaltrials.gov/ct2/show/NCT03838783?term=diabetes&sfpd_d=14 February 12, 2019 at 05:04PM via ClinicalTrials.gov New diabetes clinical trial: CGM Precision and Glycaemic Variability Published on: February 15, 2019 at 07:00PM Condition:   Diabetes Type 1 Intervention:   Other: CGM Sponsor:   Peter Vestergaard Completed https://clinicaltrials.gov/ct2/show/NCT03842683?term=diabetes&sfpd_d=14 February 15, 2019 at 07:52PM via ClinicalTrials.gov New diabetes clinical trial: Maternal Weight Gain in Gestational Diabetes Controlled by Metformin Versus Insulin Published on: February 15, 2019 at 07:00PM Condition:   Gestational Diabetes Interventions:   Drug: Insulin;   Drug: Metformin;   Other: Assessment of weight gain Sponsor:   Ain Shams University Completed https://clinicaltrials.gov/ct2/show/NCT03841591?term=diabetes&sfpd_d=14 February 15, 2019 at 07:52PM via ClinicalTrials.gov New diabetes clinical trial: A Study to Evaluate the Efficacy and Safety of Gemigliptin With in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Dapagliflozin and Metformin Published on: February 15, 2019 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: Gemigliptin 50mg;   Drug: Gemigliptin Placebo Sponsor:   LG Chem Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT03842267?term=diabetes&sfpd_d=14 February 15, 2019 at 07:52PM via ClinicalTrials.gov New diabetes clinical trial: Use of CoG by Patients With Diabetes Mellitus Published on: February 15, 2019 at 07:00PM Condition:   Diabetes Mellitus Intervention:   Device: non-invasive tissue glucose prediction Sponsors:   Sciema UG;   Cnoga Medical Ltd. Active, not recruiting https://clinicaltrials.gov/ct2/show/NCT03840161?term=diabetes&sfpd_d=14 February 15, 2019 at 07:52PM via ClinicalTrials.gov New diabetes clinical trial: Intensive Diet and Physical Activity on Diabetes Published on: February 15, 2019 at 07:00PM Conditions:   Type2 Diabetes;   Life Style Interventions:   Behavioral: intensive diet intervention;   Behavioral: Enhanced physical activity intervention;   Behavioral: Standard education Sponsor:   Shanghai Jiao Tong University School of Medicine Recruiting https://clinicaltrials.gov/ct2/show/NCT03839667?term=diabetes&sfpd_d=14 February 15, 2019 at 07:52PM via ClinicalTrials.gov New diabetes clinical trial: Who Will Benefit From Bariatric Surgery for Diabetes? Published on: February 15, 2019 at 07:00PM Conditions:   Diabetes Mellitus, Type 2;   Obesity Intervention:   Procedure: Roux-en-Y gastric bypass (RYGB) Sponsors:   Imperial College London;   National Institute for Health Research, United Kingdom Recruiting https://clinicaltrials.gov/ct2/show/NCT03842475?term=diabetes&sfpd_d=14 February 15, 2019 at 07:52PM via ClinicalTrials.gov New diabetes clinical trial: Type 2 Diabetes: Risk Perceptions and Self-management Behaviour Published on: February 15, 2019 at 07:00PM Condition:   Type 2 Diabetes Mellitus Intervention:   Other: Personalized Risk Communication for People with Type 2 Diabetes Sponsors:   University of Oxford;   NIHR Collaboration for Leadership in Applied Health Research and Care (Oxford) Completed https://clinicaltrials.gov/ct2/show/NCT03840850?term=diabetes&sfpd_d=14 February 15, 2019 at 07:52PM via ClinicalTrials.gov Manage this Applet

Weekly Update: a new vulnerability is published on the National Vulnerability Database (6 items)

New vulnerabilities from the NVD: CVE-2016-10742 Zabbix before 2.2.21rc1, 3.x before 3.0.13rc1, 3.1.x and 3.2.x before 3.2.10rc1, and 3.3.x and 3.4.x before 3.4.4rc1 allows open redirect via the request parameter. Published at: February 17, 2019 at 06:29PM View on website February 17, 2019 at 08:44PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2018-15380 A vulnerability in the cluster service manager of Cisco HyperFlex Software could allow an unauthenticated, adjacent attacker to execute commands as the root user. The vulnerability is due to insufficient input validation. An attacker could exploit this vulnerability by connecting to the cluster service manager and injecting commands into the bound process. A successful exploit could allow the attacker to run commands on the affected host as the root user. This vulnerability affects Cisco HyperFlex Software releases prior to 3.5(2a). Published at: February 21, 2019 at 01:29AM View on website February 21, 2019 at 04:57AM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2013-7469 Seafile through 6.2.11 always uses the same Initialization Vector (IV) with Cipher Block Chaining (CBC) Mode to encrypt private data, making it easier to conduct chosen-plaintext attacks or dictionary attacks. Published at: February 21, 2019 at 05:29AM View on website February 21, 2019 at 08:57AM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2013-5654 (yingzhipython) Vulnerability in YingZhi Python Programming Language v1.9 allows arbitrary anonymous uploads to the phone's storage Published at: February 15, 2019 at 11:29PM View on website February 21, 2019 at 10:57PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2014-10079 In Vembu StoreGrid 4.4.x, the front page of the server web interface leaks the private IP address in the "ipaddress" hidden form value of the HTML source code, which is disclosed because of incorrect processing of an index.php/ trailing slash. Published at: February 23, 2019 at 04:29PM View on website February 23, 2019 at 06:42PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2014-10078 Vembu StoreGrid 4.4.x has XSS in interface/registercustomer/onlineregsuccess.php, interface/registerreseller/onlineregfailure.php, interface/registerclient/onlineregfailure.php, and interface/registercustomer/onlineregfailure.php. Published at: February 23, 2019 at 04:29PM View on website February 23, 2019 at 06:42PM via National Vulnerability Database Manage this Applet

Weekly Update: New diabetes clinical trial (16 items)

New diabetes clinical trial: Copeptin After an Oral Stimulation With Macimorelin in Healthy Volunteers Published on: February 18, 2019 at 07:00PM Condition:   Central Diabetes Insipidus Interventions:   Drug: Macimorelin 0.5mg/kg body weight;   Drug: Macimorelin 0.75mg/kg body weight Sponsor:   University Hospital, Basel, Switzerland Recruiting https://clinicaltrials.gov/ct2/show/NCT03844217?term=diabetes&sfpd_d=14 February 18, 2019 at 06:31PM via ClinicalTrials.gov New diabetes clinical trial: Transition of Diabetes Care From Pediatric to Adult Healthcare Providers. Published on: February 18, 2019 at 07:00PM Condition:   Transition Intervention:   Other: Transition classes Sponsor:   Milton S. Hershey Medical Center Recruiting https://clinicaltrials.gov/ct2/show/NCT03844126?term=diabetes&sfpd_d=14 February 18, 2019 at 06:31PM via ClinicalTrials.gov New diabetes clinical trial: A Study of t:Slim X2 With Control-IQ Technology Published on: February 18, 2019 at 07:00PM Condition:   Type 1 Diabetes Mellitus Interventions:   Device: t:slim X2 with Control-IQ Technology & Dexcom G6 CGM;   Device: Standard of Care Sponsors:   University of Virginia;   Tandem Diabetes Care, Inc.;   DexCom, Inc.;   Jaeb Center for Health Research Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT03844789?term=diabetes&sfpd_d=14 February 18, 2019 at 06:31PM via ClinicalTrials.gov New diabetes clinical trial: Insulin-based Strategies to Prevent Hypoglycemia During Two Types of Exercise Published on: February 19, 2019 at 07:00PM Condition:   Type 1 Diabetes Mellitus Interventions:   Other: Continous exercise;   Other: Interval exercise;   Other: Reduction of basal insulin by 40%;   Other: Reduction of basal insulin by 80% Sponsors:   Institut de Recherches Cliniques de Montreal;   McGill University Health Center Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT03845114?term=diabetes&sfpd_d=14 February 19, 2019 at 04:41PM via ClinicalTrials.gov New diabetes clinical trial: Positive Psychology Intervention to Treat Diabetes Distress in Teens With Type 1 Diabetes Published on: February 19, 2019 at 07:00PM Condition:   Type 1 Diabetes Mellitus Interventions:   Behavioral: Check It;   Behavioral: Education Sponsors:   Vanderbilt University Medical Center;   Children's Research Institute Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT03845465?term=diabetes&sfpd_d=14 February 19, 2019 at 04:41PM via ClinicalTrials.gov New diabetes clinical trial: Cardio-metabolic and Inflammatory Impact of Starch Digestibility in Type 2 Diabetic Patients Published on: February 20, 2019 at 07:00PM Condition:   Type2 Diabetes Interventions:   Other: Balanced diet high in Slowly Digestible Starch;   Other: Balanced diet low in Slowly Digestible Starch Sponsors:   Mondelēz International, Inc.;   Centre de Recherche en Nutrition Humaine Rhone-Alpe;   Biofortis Mérieux NutriSciences Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT03847701?term=diabetes&sfpd_d=14 February 20, 2019 at 04:41PM via ClinicalTrials.gov New diabetes clinical trial: Assessments and Interventions for Hand Neuropathy in DM Published on: February 20, 2019 at 07:00PM Conditions:   Diabetes Mellitus;   Neuropathy, Diabetic Interventions:   Other: Biofeedback training;   Other: Home-based tendon gliding and resistance training Sponsor:   National Cheng-Kung University Hospital Completed https://clinicaltrials.gov/ct2/show/NCT03847129?term=diabetes&sfpd_d=14 February 20, 2019 at 04:41PM via ClinicalTrials.gov New diabetes clinical trial: Microcirculatory Vasomotor Changes in Type 2 Diabetes With Peripheral Neuropathy Published on: February 20, 2019 at 07:00PM Conditions:   Diabetic Neuropathy Peripheral;   Small Vessel Disease of Diabetes Mellitus;   Vasodilation;   Vasoconstriction Interventions:   Other: "Rest";   Other: "Exercise";   Other: "Foot lowering";   Other: "Hyperthermia" Sponsor:   University of Avignon Recruiting https://clinicaltrials.gov/ct2/show/NCT03847779?term=diabetes&sfpd_d=14 February 20, 2019 at 04:41PM via ClinicalTrials.gov New diabetes clinical trial: PRISM for Adolescents With Type 1 Diabetes Published on: February 20, 2019 at 07:00PM Condition:   Type 1 Diabetes Mellitus Intervention:   Behavioral: Promoting Resilience in Stress Management (PRISM) Sponsor:   Seattle Children's Hospital Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT03847194?term=diabetes&sfpd_d=14 February 20, 2019 at 04:41PM via ClinicalTrials.gov New diabetes clinical trial: Patient Empowerment Through Predictive Personalised Decision Support(PEPPER)-Validation Study. Published on: February 21, 2019 at 07:00PM Condition:   Diabetes Mellitus, Type 1 Intervention:   Device: PEPPER system Sponsors:   Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta;   Imperial College London;   Oxford Brookes University;   University of Girona;   Cellnovo Limited;   Romsoft SRL Enrolling by invitation https://clinicaltrials.gov/ct2/show/NCT03849755?term=diabetes&sfpd_d=14 February 21, 2019 at 06:41PM via ClinicalTrials.gov New diabetes clinical trial: A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus Published on: February 21, 2019 at 07:00PM Condition:   Type 1 Diabetes Mellitus Interventions:   Device: AID System;   Drug: Insulin Lispro Sponsor:   Eli Lilly and Company Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT03849612?term=diabetes&sfpd_d=14 February 21, 2019 at 06:41PM via ClinicalTrials.gov New diabetes clinical trial: A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus During Meal Challenges Published on: February 21, 2019 at 07:00PM Condition:   Type 1 Diabetes Mellitus Interventions:   Device: AID System;   Drug: Insulin Lispro Sponsor:   Eli Lilly and Company Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT03848767?term=diabetes&sfpd_d=14 February 21, 2019 at 06:41PM via ClinicalTrials.gov New diabetes clinical trial: A Phase 2 Study to Evaluate the Efficacy and Safety of HS-20004 in Type 2 Diabetes Subjects. Published on: February 21, 2019 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Intervention:   Drug: HS-20004 Sponsor:   Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT03848793?term=diabetes&sfpd_d=14 February 21, 2019 at 06:41PM via ClinicalTrials.gov New diabetes clinical trial: Pharmacist Impact on Pneumococcal Polysaccharide Vaccination Rates in Patients With Diabetes in a Supermarket Pharmacy Chain Published on: February 22, 2019 at 07:00PM Condition:   Pneumococcal Pneumonia Intervention:   Behavioral: Pharmacist Vaccine Education Sponsor:   Virginia Commonwealth University Recruiting https://clinicaltrials.gov/ct2/show/NCT03851978?term=diabetes&sfpd_d=14 February 23, 2019 at 12:44AM via ClinicalTrials.gov New diabetes clinical trial: Zinc Supplementation in Patients With β-Thalassemia Major Complicated With Diabetes Mellitus Published on: February 22, 2019 at 07:00PM Condition:   To Assess Effect of Zinc Supplementations on Glucose Homeostasis Intervention:   Drug: Zinc Sponsor:   Ain Shams University Completed https://clinicaltrials.gov/ct2/show/NCT03851055?term=diabetes&sfpd_d=14 February 23, 2019 at 12:44AM via ClinicalTrials.gov New diabetes clinical trial: Janagliflozin Treat Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Metformin Published on: February 22, 2019 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: Janagliflozin plus metformin;   Device: Placebo plus metformin Sponsor:   Sihuan Pharmaceutical Holdings Group Ltd. Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT03851432?term=diabetes&sfpd_d=14 February 23, 2019 at 12:44AM via ClinicalTrials.gov Manage this Applet

Снимките на Деня

Снимка за този ден February 03, 2019 at 05:30PM
С пожелания за успешен ден!
Снимка на деня от Wildlife Photo
Снимка на деня от The Telegraph
Снимка на деня от The Guardian - 10 снимки
Снимка на деня от National Geographic

Снимка на деня от Дневник